| Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes | 04/04/2025 | |
| Clinical Benefits of FcRn Inhibitors Clinical Benefits: Innovations in CIDP Management and Treatment | 03/17/2025 | |
| Novel Mechanisms of Action: FcRn Inhibitors | 03/23/2025 | |
| Implementing CIDP Clinical Guidelines: Optimizing Therapy | 03/30/2025 | |
| CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment | 03/23/2025 | |
| Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations | 04/04/2025 | |
| Autoantibodies in CIDP: Prevalence and Diagnostic Implications | 04/03/2025 | |
| Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP | 03/15/2025 | |
| Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools | 03/22/2025 | |
| Decoding CIDP: Exploring Common and Atypical Variants | 04/03/2025 | |
| Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneur… | | |
